Visual and quantitative perfusion analysis in left main stem disease: a CE-MARC substudy
verfasst von:
John P Greenwood, Ananth Kidambi, Neil Maredia, Kevin Mohee, Steven Sourbron, Manish Motwani, Akhlaque Uddin, David P Ripley, Bernhard A Herzog, Arshad Zaman, Catherine J Dickinson, Julia Brown, Jane Nixon, Colin Everett, Sven Plein
Left main stem (LMS) disease occurs in approximately 5% of patients with stable angina. It confers adverse prognosis, with potential for prognostic gain with revascularization. Single-photon emission computed tomography (SPECT) and CMR fail to detect ischemia in 41% and 18% of patients with significant LMS stenosis respectively [1], likely in part because of balanced reduction in coronary perfusion. It is not known whether quantitative assessment of myocardial blood flow (MBF) can improve diagnostic rates. The CE-MARC study prospectively enrolled 752 patients with suspected coronary artery disease, scheduled to undergo CMR, SPECT and X-ray coronary angiography [2]. We assessed the diagnostic performance of visual and quantitative perfusion CMR in CE-MARC patients with LMS disease.
Methods
All patients from the CE-MARC population with LMS disease ≥50%, or LMS equivalent disease (proximal LAD and proximal LCx ≥70%) on quantitative angiography were studied. A control group (matched for age and gender, excluding LMS or 3-vessel disease) was randomly selected from the CE-MARC population. Visual SPECT and CMR analyses were from the original, blinded read of CE-MARC. Only perfusion components of the CE-MARC CMR and SPECT protocols were analyzed. MBF was calculated offline (PMI v0.4) using the Fermi model from CMR stress perfusion images, with arterial input defined in LV blood pool, and LAD and LCx segments in the mid-LV short axis myocardial slice as tissue response.
Anzeige
Results
47 patients were included in the analysis (22 LMS, 1 LMS equivalent, 24 controls); 1 LMS patient did not have CMR. Visual detection rates for ischemia in LMS disease were non-significantly higher for CMR than SPECT (83% vs. 61%, p=0.19). On quantitative CMR perfusion analysis, stress MBF was significantly lower in LMS patients than controls (2.67±0.94 ml/g/min vs. 3.97±1.25 ml/g/min, p<0.01). ROC AUC for MBF was 0.81. An MBF cut-off of 3.78 ml/g/min was derived by Youden's Index (to objectively find optimal sensitivity and specificity). This cut-off point had sensitivity 0.96, specificity 0.67 and accuracy 0.81 for LMS disease over controls. Using this cut-off, stress MBF had higher sensitivity in LMS disease than visual SPECT analysis (96% vs. 61%, p=0.01, Figure 1), but was not significantly superior to visual CMR analysis (p=0.35).
Figure 1
Detection rates of ischemic heart disease for CMR visual analysis, CMR MBF quantitation, and SPECT in 23 patients with LMS or LMS equivalent disease.
×
Conclusions
Quantitative CMR identifies LMS disease with higher sensitivity than visual SPECT analysis. Quantitative CMR analysis of MBF compared to visual CMR analysis did increase diagnostic sensitivity numerically; however this did not reach statistical significance in this small population from CE-MARC.
Funding
CE-MARC was funded by the British Heart Foundation (BHF). JPG and SP receive an educational research grant from Philips Healthcare. SP is funded by a BHF fellowship (FS/1062/28409).
Open Access
This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License (
https://creativecommons.org/licenses/by/2.0
), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Visual and quantitative perfusion analysis in left main stem disease: a CE-MARC substudy
verfasst von
John P Greenwood Ananth Kidambi Neil Maredia Kevin Mohee Steven Sourbron Manish Motwani Akhlaque Uddin David P Ripley Bernhard A Herzog Arshad Zaman Catherine J Dickinson Julia Brown Jane Nixon Colin Everett Sven Plein
Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.
Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.
In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.
Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.
Update Radiologie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
